The global Cell Expansion Market is estimated to be valued at US$ 17927.69 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The cell expansion market involves the process of growing cells to increase the cell count for various end-use applications. Cell expansion products such as bioreactors, serum, media & reagents, and accessories help in culturing stem cells and other specialized cells. Bioreactors help in scaling up production of stem cells for clinical use under controlled conditions. Furthermore, cell expansion finds applications in the areas of research, clinical, and industrial bioprocessing for producing therapeutic proteins, vaccines, and other bio products. Growing demand for regenerative medicine and stem cell research is expected to drive growth of the cell expansion market during the forecast period.

Market key trends:

One of the key trends in the cell expansion market is increasing focus on developing automated and closed cell expansion systems. Automated cell expansion systems help standardize the process and increase productivity while maintaining sterility. For instance, Corning Inc. offers Xuri automated cell expansion system along with fed-batch bioprocess containers for scalable cell expansion from research to commercial manufacturing. Moreover, growing prevalence of chronic diseases such as cancer is creating opportunities for development of advanced cell-based therapies. This is augmenting the need for scaling up cell manufacturing processes using cell expansion techniques, thus supporting market growth over the coming years.

Porter’s Analysis

Threat of new entrants: The cell expansion market has high capital investment requirements for setting up production facilities and R&D. This acts as a barrier for new players.

Bargaining power of buyers: The presence of several players and availability of alternative options provides relatively high bargaining power to buyers.

Bargaining power of suppliers: Suppliers have limited power, as there are many suppliers for raw materials such as media and reagents.

Threat of new substitutes: There is a low threat of substitutes as cell expansion is an emerging and promising field with wide applications in developing cell-based therapeutics.

Competitive rivalry: High.

Key Takeaways

The Global Cell Expansion Market Size is expected to witness high growth, exhibiting a CAGR of 11% over the forecast period, due to increasing R&D investments by biopharmaceutical companies and growth in stem cell research activities.

On a regional basis, North America dominated the cell expansion market in 2023 and is expected to continue its dominance over the forecast period. This is attributed to growing stem cell research activities and high healthcare expenditure in the region. Asia Pacific is expected to be the fastest growing market during the forecast period owing to rising stem cell therapy adoption and increasing investments by key market players.

Key players operating in the cell expansion market are Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, Biologos, Cyagen US Inc.

*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it